Focal Therapy

Home » Treatments » Focal Therapy

Video: “Partial gland ablation for localized prostate cancer: Who is eligible and what are the risks?”

July 2017 Awareness Night Partial gland ablation for localized prostate cancer: Who is eligible and what are the risks? Dr. Nathan Perlis, MD, MSc, FRCSC Clinical assistant, Division of Urology, University Health Network Clinical fellow, Society of Urological Oncology, University of Toronto     CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 40:48 minutes

Low-Risk and Very-Low-Risk Prostate Cancer: Is There a Role for Focal Therapy in the Era of Active Surveillance? Yes, the Two Approaches Complement Each Other

The challenge in prostate cancer (PCa) is to match the aggressiveness of the treatment to that of the cancer. Until recently, all screen-diagnosed localized cancers were considered at least potentially aggressive and in most cases were treated radically. Active surveillance represented a major step forward in acknowledging that some cancers were clinically insignificant and did not pose a threat to the patient’s life. Recently, a third option—focal therapy—has emerged as a potential middle ground between radical treatment and active surveillance. Read the article.

Focal Therapy – New pain-free treatment for prostate cancer? Not quite

If you or someone close to you has lived with prostate cancer, you’ve probably come across dozens of emerging treatments in your hours of Googling. One such treatment, focal therapy, has been dubbed the “new pain-free treatment for prostate cancer”. But don’t hold your breath; it’s still in its experimental phases. This is a warning that focal therapy is still experimental and should be considered only in a clinical trial setting.  Read the article.

Focal Therapy for Prostate Cancer Advances

Laser ablation, cryotherapy, and hemiablative brachytherapy are among the novel approaches that show promise for the focal treatment of localized prostate cancer (PCa), according to studies presented at the 28th annual congress of the European Association of Urology. Most of these treatments are performed under magnetic resonance imaging (MRI) guidance. Read the article.

Focal Therapy Offers Middle Ground for Some Prostate Cancer Patients

Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option. Focal laser ablation uses precisely targeted heat, delivered through a small insertion and guided into the prostate by magnetic resonance imaging, to burn away cancerous cells in the prostate. Read the article.

Scroll to Top